Unidad de Investigacion Clinica en Medicina SC.
Monterrey, Nuevo León, 64020, Mexico
NCT Number: NCT00551408
Endothelial dysfunction ultimately represents an imbalance between the magnitude of injury and the capacity for repair.
Current evidence established that endothelial progenitor cells (EPC) participate in several models of vascular disease as acute coronary syndromes, stroke, diabetes, peripheral artery disease, etc. However EPC in the setting of PAH is less well established. The target of this study is to demonstrate if the number of EPC is increased in a mexican population of patients with PAH.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
Monterrey, Nuevo León, 64020, Mexico
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Unidad de Investigacion Clinica en Medicina S.C.
Network
The Determination of Endothelial Progenitor Cells in Pulmonary Idiopathic Arterial Hypertension.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03626688
Cardiovascular Diseases, Connective Tissue Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT05343637
Cardiovascular Diseases, Familial Primary Pulmonary Hypertension
Darlinghurst, New South Wales, Australia
View Trial DetailsNCT04610788
Connective Tissue Diseases, Familial Primary Pulmonary Hypertension
Baltimore, Maryland, United States
View Trial DetailsNCT04908397
Carnitine Nutritional Deficiency, Familial Primary Pulmonary Hypertension
Nashville, Tennessee, United States
View Trial Details